drugset / Trial / NCT01665196
18F-FDG PET/CT for IgG4-Related Disease
NaSingle-groupOpen-labelDiagnostic
Summary
This is an open-label study to investigate the diagnostic performance of 18F-FDG PET/CT (positron emission tomography/computed tomography) in evaluation of patients with IgG4-related disease. A single dose of 18F-FDG will be intravenously injected into patients with IgG4-related disease before and after treatment.
Timeline
- Start
- 2012-09
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FDG | Diagnostic / imaging agent | — | Intravenous |